Glatiramer acetate

Details

Files
Generic Name:
Glatiramer acetate
Project Status:
Complete
Therapeutic Area:
Clinically Isolated Syndrome (CIS), suggestive of Multiple Sclerosis
Manufacturer:
Teva Pharmaceutical Industries Ltd.
Brand Name:
Copaxone
Project Line:
Reimbursement Review
Project Number:
SR0164-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Clinically Isolated Syndrome (CIS), suggestive of Multiple Sclerosis
Recommendation Type:
Do not list
Final Recommendation: